A study to evaluate whether a drug, levetiracetam decreases anxiety associated with elective laparoscopic gall bladder surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Patient with physical status ASA I and II, are scheduled for elective laparoscopic cholecystectomy
- Registration Number
- CTRI/2014/01/004323
- Lead Sponsor
- azareth Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 102
Inclusion Criteria
Patients with physical status ASA I and II, are scheduled for elective laparoscopic cholecystectomy
Exclusion Criteria
1. Age < 18 years or >70years
2. body mass index (BMI) <19 and >35 kg/m2
3. known sensitivity to study drugs
4. inability to tolerate oral medication and understand the anxiety (VAS) score,
5. has cardiac problem, renal or hepatic dysfunction, respiratory disease or any psychiatric problem.
6. on chronic pain medication, anticonvulsant or antidepressant.
7. pregnant patients
8. Patients are not giving consent to get enrolled in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method level of anxiety in terms of visual analogue score before surgeryTimepoint: level of anxiety in terms of visual analogue score will be assessed before giving the study drug, at pre operative holding area before entering to operation theater, at operation theater just before administering anaesthesia
- Secondary Outcome Measures
Name Time Method sedation levelTimepoint: just before giving the study drug, at pre operative holding area before entering to operation theater, on operation theater table just before induction of anesthesia